Manuscripts
Showing 1551 manuscripts.
Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/delta NS2/delta 1313/I1314L and RSV/276 in RSV-Seronegative Children
Citation
Petronella Muresan, Mariam Aziz, Matthew S. Kelly, Lijuan Yang, Elizabeth J. McFarland, Cindy Luongo, Charlotte Perlowski, Peter L. Collins, Jennifer Libous, Ursula J. Buchholz, Jennifer Oliva, IMPAACT 2018 Study Team, Patrick Jean-Philippe, Jack Moye Jr., Elizabeth Schappell, Emily Barr, Vivian Rexroad, Benjamin Johnston, Ellen G. Chadwick, Mikhaela Cielo, Coleen K. Cunningham, Mary Paul, Ruth A. Karron, Jaime G. Deville. Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/delta NS2/delta 1313/I1314L and RSV/276 in RSV-Seronegative Children. Journal of Infectious Diseases. 2022. 226: 2069-2078. PMID: 35732186Year
2022
Journal
Journal of Infectious Diseases
Study
IMPAACT 2018
Pharmacokinetics and Safety of Three Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women
Citation
Paula Britto, Amita Gupta, Priya Jayachandran, Kelly E Dooley, Lubbe Wiesner, IMPAACT 2001 Study Team, Grace Montepiedra, Jennifer Norman, Nan Zhang, Ellen Townley, Nahida Chakhtoura, Sarah Bradford, Sandesh Patil, Stephanie Popson, Tsungai Chipato, Vanessa Rouzier, Deborah Langat, Jyoti S Mathad, Amphan Chalermchockcharoentkit, Rada Savic, Portia Kamthunzi. Pharmacokinetics and Safety of Three Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women. Clinical Infectious Diseases. 2022. 74: 1604-1613. PMID: 34323955Year
2022
Journal
Clinical Infectious Diseases
Study
IMPAACT 2001
Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study
Citation
Avy Violari, IMPAACT P1106 team, Mark F. Cotton, Mae Cababasay, Jiajia Wang, Ruth Mathiba, Lubbe Wiesner, Andrew Wiznia, Pearl Samson, Renee Browning, Jack Moye, Firdose L. Nakwa, Bobbie Graham, Eric Decloedt, Helena Rabie, Adrie Bekker, Mark Mirochnick, Edmund V. Capparelli, Tim R. Cressey. Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study. Lancet HIV. 2022. PMID: 27936233Year
2022
Journal
Lancet HIV
Study
P1106
Influence of NAT2 genotype and maturation on isoniazid exposure in low-birth-weight and preterm infants with or without HIV exposure
Citation
Belén P. Solans, Mark F. Cotton, Mark Mirochnick, Avy Violari, Jiajia Wang, Mae Cababasay, Lubbe Wiesner, Renee Browning, Jack Moye, Edmund V. Capparelli, Radojka M. Savic, Agathe Béranger, Adrie Bekker. Influence of NAT2 genotype and maturation on isoniazid exposure in low-birth-weight and preterm infants with or without HIV exposure. Clinical Infectious Diseases. 2022. PMID: 35134861Year
2022
Journal
Clinical Infectious Diseases
Study
P1106
Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term
Citation
Esaú C João, Sheila M. Styrchak, Samantha R. Hardy, Jackson J. Wallner, Ross S. Milne, R. Leavitt Morrison, David Shapiro, Mark Mirochnick, Lisa M. Frenkel, Ceejay L. Boyce, Ingrid A. Beck. Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term. PLoS One. 2022. 17: e0275254. PMID: 36166463Year
2022
Journal
PLoS One
Study
P1081
Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081
Citation
Geraldo Duarte, Alice Stek, Avy Violari, Cristina B. Hofer, Jaime G. Deville, James Samwel Ngocho, José Henrique Pilotto, Mario Dias Correa Jr., David E. Shapiro, Trevon L. Fuller, Nahida Chakhtoura, Mark Mirochnick, Esaú C. João, Conrado Milani Coutinho, Meredith G. Warshaw. Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081. Journal of Acquired Immune Deficiency Syndromes. 2022. 91: 403-409. PMID: 36049477Year
2022
Journal
Journal of Acquired Immune Deficiency Syndromes
Exploring the value of Mycobacterium tuberculosis modified lipoprotein as a potential biomarker for TB detection in children
Citation
Sharon Nachman, Nicole S Sampson, Xinxin Yang, Matthew F Wipperman. Exploring the value of Mycobacterium tuberculosis modified lipoprotein as a potential biomarker for TB detection in children. BMC Infectious Diseases. 2022. 22: 158. PMID: 35177035Year
2022
Journal
BMC Infectious Diseases
Study
P1041
Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action
Citation
Angela Colbers, Françoise Renaud, Alexandra Calmy, Polly Clayden, Marissa Vicari, Imelda C Mahaka, Jennifer M Zech, Cadi Irvine, Elaine J Abrams, Participants of the WHO-IMPAACT Workshop “Approaches to Enhance and Accelerate Study of New Drugs for HIV and Associated Infections in Pregnant Women”, Martina Penazzato, Shahin Lockman. Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action. Journal of the International AIDS Society. 2022. 25: e25912. PMID: 35851834Year
2022
Journal
Journal of the International AIDS Society
Caregiver willingness to give TPT to children living with drug-resistant TB patients
Citation
S Kim, L Naini, J Shenje, E Mitchell, M Raesi, M Lourens, A Mendoza, F Conradie, N Suryavanshi, M Hughes, S Shah, G Churchyard, S Swindells, A Hesseling, V Rouzier, A Gupta, M Murrill. Caregiver willingness to give TPT to children living with drug-resistant TB patients. International Journal of Tuberculosis and Lung Disease. 2022. 26: 949-955. PMID: 36163664Year
2022
Journal
International Journal of Tuberculosis and Lung Disease
Study
IMPAACT 2003/ACTG 5300
Hepatotoxicity and Liver-Related Mortality in Women of Childbearing Potential Living With Human Immunodeficiency Virus and High CD4 Cell Counts Initiating Efavirenz-Containing Regimens
Citation
Camlin Tierney, Sharon Huang, Marion Peters, Tsungai Chipato, Frances Martinson, Neaka Mohtashemi, Dingase Dula, Kathy George, Nahida Chaktoura, Karin L Klingman, Devasena Gnanashanmugam, Judith S Currier, Mary G Fowler, Debika Bhattacharya, Amita Gupta. Hepatotoxicity and Liver-Related Mortality in Women of Childbearing Potential Living With Human Immunodeficiency Virus and High CD4 Cell Counts Initiating Efavirenz-Containing Regimens. Clinical Infectious Diseases. 2021. 72: 1342-1349. PMID: 32161944Year
2021
Journal
Clinical Infectious Diseases
Study
1077BF, 1077FF